InMed Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying

2/23/24 7:34:16 AM ET

Finance: Consumer Services

Finance

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $BENF alert in real time by email

The Dow Jones index closed higher by over 450 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

GeoVax Labs

The Trade: GeoVax Labs, Inc. (NASDAQ:GOVX) President, CEO David A Dodd acquired a total of 8,729 shares an average price of $2.27. To acquire these shares, it cost around $19,781.
What’s Happening: GeoVax is expected to report 2023 financial results on Feb. 29, 2024.
What GeoVax Labs Does: Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms.

Beneficient

The Trade: Beneficient (NASDAQ:BENF) Director Peter T Cangany Jr acquired a total of 400,000 shares at at an average price of $0.26. To acquire these shares, it cost around $102,000.
What’s Happening: On Feb. 13, Beneficient posted a wider quarterly loss.
What Beneficient Does: Beneficient is a technology-enabled financial services holding company that (together with its subsidiaries) provides simple, rapid, and cost-effective liquidity solutions to participants in the alternative asset industry through its end-to-end online platform, AltAccess.

Check This Out: Warner Bros. Discovery, Block And 3 Stocks To Watch Heading Into Friday

InMed Pharmaceuticals

The Trade: InMed Pharmaceuticals Inc. (NASDAQ:INM) Director Andrew Hull acquired a total of 37,500 shares at an average price of $0.39. The insider spent around $14,625 to buy those shares.
What’s Happening: InMed Pharmaceuticals, on Oct. 24, said it selected a lead Alzheimer's drug candidate following positive proof-of-concept study data.
What InMed Pharmaceuticals Does: InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company.

Don’t forget to check out our premarket coverage here

Get the next $BENF alert in real time by email

Crush Q1 2026 with the Best AI Superconnector

Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

AI-Powered Inbox

Context-aware email replies

Strategic Decision Support

Get Started with Standout.work

Recent Analyst Ratings for
$BENF
$GOVX
$INM

Company	Date	Price Target	Rating	Analyst
GeoVax Labs Inc. $GOVX	2/19/2026		Buy → Hold	D. Boral Capital
GeoVax Labs Inc. $GOVX	4/15/2025	$18.00 → $14.00	Buy	D. Boral Capital
GeoVax Labs Inc. $GOVX	4/15/2025	$15.00 → $8.50	Buy	Alliance Global Partners
GeoVax Labs Inc. $GOVX	11/11/2024	$15.00	Buy	Alliance Global Partners
GeoVax Labs Inc. $GOVX	7/16/2024	$20.00	Buy	ROTH MKM
InMed Pharmaceuticals Inc. $INM	11/29/2021	$6.00	Buy	HC Wainwright & Co.

More analyst ratings

Beneficient Appoints Mack H. Hicks to Board of Directors

DALLAS, March 12, 2026 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced the appointment of Mack H. Hicks as a member of the Company's Board of Directors (the "Board"). Mr. Hicks currently serves as Chief Executive Officer of Hicks Holdings LLC, the Dallas-based family office with operating private equity and real estate investment businesses founded by his late father and private equity pioneer, Thomas O. Hicks, who served as Chairman of the Board of Beneficient until his passing in December of 2025. Mr. Hicks also

3/12/26 7:30:00 AM ET

Finance: Consumer Services

Finance

Beneficient Reports Third Quarter Fiscal 2026 Results

DALLAS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today reported its financial results for the fiscal 2026 third quarter, which ended December 31, 2025. Highlights of the quarter include: Resolved GWG Holdings, Inc. litigation and regained Nasdaq complianceGenerated $50 million in gross proceeds from asset salesFully paid off HH-BDH Credit Agreement principal balance (excluding $1.7 million for deferred interest and fees)Strengthened balance sheet and collateral base Commenting on the

2/17/26 5:00:00 PM ET

Finance: Consumer Services

Finance

Beneficient Announces Third Quarter Fiscal 2026 Earnings Release and Webcast

DALLAS, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced that it will release its Third Quarter Fiscal 2026 financial results and host a webcast to present the results on Tuesday, February 17, 2026. The webcast will take place that day at 5:30 p.m. Eastern Standard Time. To listen to the webcast please visit the Beneficient investor relations website at shareholders.trustben.com at least ten minutes prior to the scheduled start time to register. A replay of the webcast will be

2/12/26 4:15:00 PM ET

Finance: Consumer Services

Finance

$BENF
$GOVX
$INM
Leadership Updates

Live Leadership Updates

Beneficient Appoints Mack H. Hicks to Board of Directors

DALLAS, March 12, 2026 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced the appointment of Mack H. Hicks as a member of the Company's Board of Directors (the "Board"). Mr. Hicks currently serves as Chief Executive Officer of Hicks Holdings LLC, the Dallas-based family office with operating private equity and real estate investment businesses founded by his late father and private equity pioneer, Thomas O. Hicks, who served as Chairman of the Board of Beneficient until his passing in December of 2025. Mr. Hicks also

3/12/26 7:30:00 AM ET

Finance: Consumer Services

Finance

Beneficient Appoints Peter T. Cangany Jr. as Chairman of the Board

DALLAS, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced that its Board of Directors (the "Board") has appointed Peter T. Cangany Jr. as Chairman of the Board, effective December 15, 2025. Mr. Cangany has served as a director of Beneficient and as Chairman of its independent Audit Committee since 2019. He brings decades of leadership experience in financial reporting, accounting, and corporate governance within the financial services industry. Mr. Cangany retired as a partner

12/17/25 7:30:00 AM ET

Finance: Consumer Services

Finance

Beneficient Appoints Tom Hicks as Chairman and James Silk as Interim Chief Executive Officer

DALLAS, July 21, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform AltAccess, today announced the separation of the roles of Chairman of the Board of Directors ("Board") and Chief Executive Officer with the appointment of Thomas O. Hicks as Chairman of the Board and James G. Silk as its interim Chief Executive Officer. Mr. Hicks is a private equity pioneer with a decades-long record of success. He founded one of the early prominent private equity firms through whic

7/21/25 7:00:00 AM ET

Finance: Consumer Services

Finance

$BENF
$GOVX
$INM
Financials

Live finance-specific insights

Beneficient Reports Third Quarter Fiscal 2026 Results

DALLAS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today reported its financial results for the fiscal 2026 third quarter, which ended December 31, 2025. Highlights of the quarter include: Resolved GWG Holdings, Inc. litigation and regained Nasdaq complianceGenerated $50 million in gross proceeds from asset salesFully paid off HH-BDH Credit Agreement principal balance (excluding $1.7 million for deferred interest and fees)Strengthened balance sheet and collateral base Commenting on the

2/17/26 5:00:00 PM ET

Finance: Consumer Services

Finance

Beneficient Reports Results for Second Quarter Fiscal 2026

DALLAS, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today reported its financial results for the fiscal 2026 second quarter, which ended September 30, 2025. Commenting on the fiscal 2026 second quarter results, interim Chief Executive Officer James Silk said: "The second quarter results demonstrate our disciplined approach to managing both our investment portfolio and operating expenses during a pivotal period for Beneficient. We reduced expenses, completed new primary capital transaction

11/14/25 5:15:00 PM ET

Finance: Consumer Services

Finance

Beneficient Reports Results for First Quarter Fiscal 2026

DALLAS, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform, AltAccess, today reported its financial results for the fiscal 2026 first quarter, which ended June 30, 2025. Commenting on the fiscal 2026 first quarter results, interim Chief Executive Officer James Silk said: "This quarter reflects meaningful progress strengthening Beneficient's financial and operational foundation. We've taken deliberate steps to reduce expenses, complete new primary capital tr

10/21/25 7:30:00 AM ET

Finance: Consumer Services

Finance